CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Series A & B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Non-Controlling Interest [Member]	Total
Balance at beginning at Dec. 31, 2018	$ 126	$ 101	$ 77,647,544	$ (55,721,115)	$ (3,902,523)	$ 40,658	$ 18,064,791
Balance at beginning (in shares) at Dec. 31, 2018	126,434	100,910
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation: Options			681,079				681,079
Stock based compensation: Common stock		$ 29	304,990				305,019
Stock based compensation: Common Stock (Shares)		29,375
Issuance of common stock for cash		$ 1,333	9,869,176				9,870,509
Issuance of common stock for cash (in shares)		1,331,509
Issuance of common stock in payment of accrued liabilities		$ 9	108,514				108,523
Issuance of common stock in payment of accrued liabilities (in shares)		9,375
Issuance of common stockupon exercise of warrants		$ 700	6,620,325				6,621,025
Issuance of common stock upon exercise of warrants (in shares)		699,887
Issuance of Series A preferred stock for cash	$ 6		140,144				140,150
Issuance of Series A preferred stock for cash (in shares)	5,606
Issuance of common stock for conversion of debt		$ 370	4,735,924				4,736,294
Issuance of common stock for conversion of debt (in shares)		370,473
Beneficial conversion feature in connection with convertible notes			821,452				821,452
Fair value warrants issued in connection with convertible notes			200,518				200,518
Cash for exchange fees and other financing costs			(1,401,763)				(1,401,763)
Loss on debt extinguishment			155,448				(963,232)
Comprehensive loss:
Net loss				(21,078,358)			(21,078,358)
Preferred dividends				(12,437)			(12,437)
Net unrealized loss on derivatives in related party					(1,513,661)		(1,513,661)
Foreign currency translation adjustments					259,671		259,671
Net loss attributable to non-controlling interest						(32,416)	(32,416)
Balance at ending at Sep. 30, 2019	$ 132	$ 2,542	99,883,351	(76,811,910)	(5,156,513)	8,242	17,925,844
Balance at ending (in shares) at Sep. 30, 2019	132,040	2,541,529
Balance at beginning at Jun. 30, 2019	$ 132	$ 1,037	92,377,366	(66,465,775)	(4,071,199)	8,242	21,849,803
Balance at beginning (in shares) at Jun. 30, 2019	132,040	1,037,128
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation: Options			187,125				187,125
Stock based compensation: Common stock		$ 20	51,980				52,000
Stock based compensation: Common Stock (Shares)		20,000
Issuance of common stock for cash		$ 1,141	4,415,624				4,416,765
Issuance of common stock for cash (in shares)		1,140,330
Issuance of common stock for conversion of debt		$ 344	2,127,493				2,127,837
Issuance of common stock for conversion of debt (in shares)		344,071
Beneficial conversion feature in connection with convertible notes			633,004				633,004
Fair value warrants issued in connection with convertible notes			142,070				142,070
Cash for exchange fees and other financing costs			(206,759)				(206,759)
Loss on debt extinguishment			155,448				(155,448)
Comprehensive loss:
Net loss				(10,340,851)			(10,340,871)
Preferred dividends				(5,284)			(5,284)
Net unrealized loss on derivatives in related party					(1,152,480)		(1,152,480)
Foreign currency translation adjustments					67,166		67,166
Balance at ending at Sep. 30, 2019	$ 132	$ 2,542	99,883,351	(76,811,910)	(5,156,513)	8,242	17,925,844
Balance at ending (in shares) at Sep. 30, 2019	132,040	2,541,529
Balance at beginning at Dec. 31, 2019	$ 132	$ 3,318	101,099,347	(88,650,465)	(5,511,624)	8,242	6,948,950
Balance at beginning (in shares) at Dec. 31, 2019	132,040	3,318,390
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation: Options			60,534				60,534
Stock based compensation: Common stock		$ 102	182,473				182,575
Stock based compensation: Common Stock (Shares)		102,500
Issuance of common stock in payment of short term advances, related party		$ 661	739,287				739,948
Issuance of common stock in payment of short term advances, related party (in shares)		660,667
Issuance of common stock in payment of accrued liabilities		$ 153	228,548				228,701
Issuance of common stock in payment of accrued liabilities (in shares)		153,124
Issuance of common stock for conversion of debt		$ 7,239	16,703,564				16,710,803
Issuance of common stock for conversion of debt (in shares)		7,238,729
Beneficial conversion feature in connection with convertible notes			81,621				81,621
Fair value warrants issued in connection with convertible notes			3,173,205				3,173,205
Cash for exchange fees and other financing costs			(25,000)				(25,000)
Loss on debt extinguishment							(13,297,793)
Comprehensive loss:
Net loss				(24,641,437)			(24,641,437)
Preferred dividends				(10,327)			(10,327)
Net unrealized loss on derivatives in related party					1,080,034		1,080,034
Foreign currency translation adjustments					(7,853)		(7,853)
Balance at ending at Sep. 30, 2020	$ 132	$ 11,473	122,243,579	(113,302,229)	(4,439,443)	8,242	4,521,754
Balance at ending (in shares) at Sep. 30, 2020	132,040	11,473,410
Balance at beginning at Jun. 30, 2020	$ 132	$ 6,112	105,625,502	(96,564,940)	(6,044,244)	8,242	3,030,804
Balance at beginning (in shares) at Jun. 30, 2020	132,040	6,112,117
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation: Options			20,400				20,400
Stock based compensation: Common stock		$ 37	109,088				109,125
Stock based compensation: Common Stock (Shares)		37,500
Issuance of common stock for conversion of debt		$ 5,324	14,016,853				14,022,177
Issuance of common stock for conversion of debt (in shares)		5,323,793
Beneficial conversion feature in connection with convertible notes			15,039				15,039
Fair value warrants issued in connection with convertible notes			2,481,697				2,481,697
Cash for exchange fees and other financing costs			(25,000)				(25,000)
Loss on debt extinguishment							(12,823,039)
Comprehensive loss:
Net loss				(16,734,356)			(16,734,356)
Preferred dividends				(2,933)			(2,933)
Net unrealized loss on derivatives in related party					1,561,247		1,561,247
Foreign currency translation adjustments					43,554		43,554
Balance at ending at Sep. 30, 2020	$ 132	$ 11,473	$ 122,243,579	$ (113,302,229)	$ (4,439,443)	$ 8,242	$ 4,521,754
Balance at ending (in shares) at Sep. 30, 2020	132,040	11,473,410